Gain (Loss), Foreign Currency Transaction, before Tax

Name: BioCryst Pharmaceuticals Gain (Loss), Foreign Currency Transaction, before Tax by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioCryst Pharmaceuticals·Business Segments·1 segment·Rolls up to Other Income (Expense)

Breakdown

Segment	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$63K	$35K	-$125K	-$225K
Total	-$23.3M	-$17.46M	-$12.37M	-$19.21M

Segments

Business SegmentsView metric